Consistently, blockade of IL‐18 by administration of a monoclonal antibody or anti‐sense IL‐18 mRNA could alleviate DSS‐ and trinitrobenzene sulfonic acid‐induced colitis in mice due to decreased production of IFN‐γ and TNF.37 This evidence concerns the gene IL18 and colitis.